NEO:BMND - Post Discussion
Post by
whytestocks on Feb 29, 2024 10:30am
Biomind Labs Announces Unprecedented Positive Results of Pha
BREAKING NEWS: $BMNDF Biomind Labs Announces Unprecedented Positive Results of Phase 2 Clinical Trial of BMND08 for Depression & Anxiety in Alzheimer's DiseaseBiomind Labs Inc. (“ Biomind ” or the “ Company ”) ( NEO: BMND ) ( OTC: BMNDF ) ( FSE: 3XI ), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological disorders by targeti...
BMNDF - Biomind Labs Announces Unprecedented Positive Results of Phase 2 Clinical Trial of BMND08 for Depression & Anxiety in Alzheimer's Disease
Be the first to comment on this post